アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/11/04 | 47,000 | 47,100 | 46,000 | 47,100 | +600 | +1.3% | 283 |
2011/11/02 | 47,000 | 47,000 | 44,500 | 46,500 | -1,100 | -2.3% | 626 |
2011/11/01 | 48,200 | 48,550 | 47,600 | 47,600 | +100 | +0.2% | 511 |
2011/10/31 | 48,200 | 48,600 | 47,500 | 47,500 | ±0 | ±0% | 451 |
2011/10/28 | 47,000 | 48,300 | 46,700 | 47,500 | +250 | +0.5% | 840 |
2011/10/27 | 48,450 | 48,700 | 46,550 | 47,250 | -950 | -2% | 1,614 |
2011/10/26 | 50,700 | 50,700 | 46,100 | 48,200 | -4,700 | -8.9% | 2,322 |
2011/10/25 | 55,500 | 55,900 | 52,800 | 52,900 | -4,600 | -8% | 956 |
2011/10/24 | 59,900 | 59,900 | 56,500 | 57,500 | -1,500 | -2.5% | 269 |
2011/10/21 | 59,900 | 59,900 | 59,000 | 59,000 | -900 | -1.5% | 59 |
2011/10/20 | 60,300 | 60,400 | 59,200 | 59,900 | -800 | -1.3% | 56 |
2011/10/19 | 60,800 | 61,000 | 59,800 | 60,700 | -300 | -0.5% | 116 |
2011/10/18 | 61,300 | 61,300 | 60,500 | 61,000 | -400 | -0.7% | 63 |
2011/10/17 | 62,200 | 63,000 | 60,300 | 61,400 | -1,800 | -2.8% | 123 |
2011/10/14 | 63,000 | 64,000 | 62,900 | 63,200 | -1,400 | -2.2% | 77 |
2011/10/13 | 64,500 | 65,900 | 63,700 | 64,600 | +200 | +0.3% | 89 |
2011/10/12 | 63,100 | 64,800 | 63,100 | 64,400 | +800 | +1.3% | 27 |
2011/10/11 | 64,100 | 65,800 | 62,800 | 63,600 | -300 | -0.5% | 94 |
2011/10/07 | 62,400 | 64,000 | 62,400 | 63,900 | +900 | +1.4% | 33 |
2011/10/06 | 63,900 | 65,000 | 62,000 | 63,000 | +100 | +0.2% | 55 |
2011/10/05 | 64,500 | 65,300 | 60,000 | 62,900 | -2,400 | -3.7% | 87 |
2011/10/04 | 67,000 | 67,000 | 64,000 | 65,300 | -2,700 | -4% | 59 |
2011/10/03 | 65,600 | 68,500 | 65,600 | 68,000 | +1,000 | +1.5% | 116 |
2011/09/30 | 65,500 | 67,000 | 64,100 | 67,000 | +2,000 | +3.1% | 86 |
2011/09/29 | 62,600 | 65,400 | 62,000 | 65,000 | +1,800 | +2.8% | 88 |
2011/09/28 | 63,300 | 63,900 | 62,500 | 63,200 | +1,000 | +1.6% | 87 |
2011/09/27 | 60,000 | 64,200 | 60,000 | 62,200 | +4,100 | +7.1% | 127 |
2011/09/26 | 67,100 | 67,100 | 58,100 | 58,100 | -10,000 | -14.7% | 387 |
2011/09/22 | 69,500 | 70,000 | 68,000 | 68,100 | -900 | -1.3% | 114 |
2011/09/21 | 70,000 | 70,000 | 68,400 | 69,000 | -1,000 | -1.4% | 40 |
2011/09/20 | 70,400 | 71,500 | 69,000 | 70,000 | -1,000 | -1.4% | 62 |
2011/09/16 | 71,000 | 71,100 | 69,700 | 71,000 | +200 | +0.3% | 31 |
2011/09/15 | 69,300 | 70,800 | 68,000 | 70,800 | +1,600 | +2.3% | 49 |
2011/09/14 | 72,000 | 72,000 | 69,100 | 69,200 | -1,600 | -2.3% | 75 |
2011/09/13 | 71,800 | 73,000 | 70,200 | 70,800 | -1,000 | -1.4% | 162 |
2011/09/12 | 69,000 | 72,500 | 67,900 | 71,800 | +2,100 | +3% | 185 |
2011/09/09 | 70,000 | 70,000 | 68,300 | 69,700 | +700 | +1% | 23 |
2011/09/08 | 68,200 | 70,500 | 67,500 | 69,000 | +1,800 | +2.7% | 97 |
2011/09/07 | 67,600 | 68,400 | 67,000 | 67,200 | +100 | +0.1% | 62 |
2011/09/06 | 68,400 | 68,500 | 67,000 | 67,100 | -1,200 | -1.8% | 77 |
2011/09/05 | 67,700 | 68,500 | 67,200 | 68,300 | -400 | -0.6% | 48 |
2011/09/02 | 69,700 | 72,000 | 68,500 | 68,700 | +200 | +0.3% | 124 |
2011/09/01 | 69,400 | 69,500 | 68,500 | 68,500 | -700 | -1% | 60 |
2011/08/31 | 68,300 | 69,300 | 68,300 | 69,200 | +900 | +1.3% | 55 |
2011/08/30 | 68,100 | 69,300 | 68,100 | 68,300 | ±0 | ±0% | 14 |
2011/08/29 | 67,200 | 69,800 | 67,200 | 68,300 | +100 | +0.1% | 75 |
2011/08/26 | 67,800 | 68,200 | 67,100 | 68,200 | +200 | +0.3% | 26 |
2011/08/25 | 68,100 | 68,200 | 67,500 | 68,000 | +500 | +0.7% | 20 |
2011/08/24 | 69,000 | 69,800 | 67,000 | 67,500 | -1,500 | -2.2% | 56 |
2011/08/23 | 68,500 | 70,700 | 66,800 | 69,000 | +2,000 | +3% | 82 |
3301~
3350
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 7,800円 | +110.0% | - | 0.00% | - | 12.68倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
ダイト | 209,600円 | +4.5% | -33.7% | 3.34% | 21.11倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ミズホメディ | 150,300円 | +1.2% | -13.9% | 5.66% | 8.86倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
扶桑薬 | 238,800円 | +8.3% | +98.1% | 3.43% | 7.85倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
CANBAS | 103,600円 | - | - | 0.00% | - | 6.63倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム